Search Results - "Gersh, B.J."

Effectiveness And Safety Of Reduced Dose Non-Vitamin K Antagonist Oral Anticoagulants In Patients Without Severe Renal Impairment by Yao, X, Shah, N.D, Sangaralingham, L.R, Gersh, B.J

Get full text

Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation by SZCZECH, L. A, BEST, P. J, WHITLOW, P. J, DETRE, K. M, HOLMES, D, CROWLEY, E, BROOKS, M. M, BERGER, P. B, BITTNER, V, GERSH, B. J, JONES, R, CALIFF, R. M, TING, H. H

“…Although severe chronic kidney disease (CKD) is an independent predictor of mortality among patients with coronary artery disease, the impact of mild CKD on…”
Get full text

Antithrombotic Strategies and Adverse Outcomes in Acute Coronary Syndrome and Atrial Fibrillation: A Community Study by Chamberlain, A.M, Gersh, B.J, Klaskala, W, Mills, R.M, Alonso, A, Weston, S.A, Roger, V.L

Get full text

Impact of Identification of Amyloidosis on the Prognosis of Patients with Hypertrophic Cardiomyopathy Undergoing Septal Myectomy for Left Ventricular Outflow Tract Obstruction by Kunkala, M, Edwards, W.D, Nishimura, R.A, Gersh, B.J, Dearani, J.A, Ommen, S.R, Mereuta, O.M, Thies, J.D, Dogan, A, Schaff, H.V

Get full text

Antithrombotic strategies in acute coronary syndrome and atrial fibrillation: A community perspective by Chamberlain, A.M, Gersh, B.J, Klaskala, W, Mills, R.M, Alonso, A, Weston, S.A, Roger, V.L

Get full text

PCV98 Impact of Atrial Fibrillation on Health Care Utilization among Patients with Myocardial Infarction by Chamberlain, A.M, Bielinski, S.J, Weston, S.A, Klaskala, W, Mills, R.M, Gersh, B.J, Roger, V.L

Get full text

173 Silent atrial fibrillation in olmsted county: A community-based study by Tsang, T.S, Barnes, M.E, Pellikka, P.A, Gin, K, Miyasaka, Y, Seward, J.B, Gersh, B.J

Get full text

476: Diagnostic Accuracy of Out-Of-Hospital Electrocardiograms Interpreted by Paramedics In the Field by Nestler, D.M, White, R.D, Rihal, C.S, Myers, L.A, Bjerke, C.M, Lennon, R.J, Schultz, J.L, Bell, M.R, Gersh, B.J, Holmes, D.R, Ting, H.H

Get full text

Left Atrial Phasic Dysfunction: A Potent Marker for First Atrial Fibrillation or Flutter in an Elderly Cohort by Abhayaratna, W.P, Fatema, K, Barnes, M.E, Seward, J.B, Gersh, B.J, Tsang, T.S

Get full text

Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry by Beyer-Westendorf, J, Camm, A.J, Virdone, S, Fox, K.A.A, Pieper, K.S, Le Heuzey, J.-Y, Haas, S, Kayani, G, Gersh, B.J, Turpie, A.G.G, Kakkar, A.K

Get full text

Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry – is dosing according to renal function appropriate? by Camm, A.J, Virdone, S, Fox, K.A.A, Pieper, K.S, Beyer-Westendorf, J, Le Heuzey, J.-Y, Haas, S, Kayani, G, Gersh, B.J, Turpie, A.G.G, Kakkar, A.K

Get full text

Progressive left ventricular post-infarction remodelling: impact on outcome by Van Der Bijl, P, Abou, R, Goedemans, L, Gersh, B.J, Holmes, D.R, Pellikka, P.A, Ajmone Marsan, N, Delgado, V, Bax, J.J

Get full text

CV2 - Effectiveness And Safety Of Reduced Dose Non-Vitamin K Antagonist Oral Anticoagulants In Patients Without Severe Renal Impairment by Yao, X., Shah, N.D., Sangaralingham, L.R., Gersh, B.J.

Get full text

D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial by Christersson, C., Wallentin, L., Andersson, U., Alexander, J. H., Ansell, J., De Caterina, R., Gersh, B. J., Granger, C. B., Hanna, M., Horowitz, J. D., Huber, K., Husted, S., Hylek, E. M., Lopes, R. D., Siegbahn, A.

“…Background D‐dimer is related to adverse outcomes in arterial and venous thromboembolic diseases. Objectives To evaluate the predictive value of D‐dimer level…”
Get full text

P3613Clinical outcomes in patients with atrial fibrillation and echocardiographic risk factors for stroke anticoagulated with apixaban or warfarin by Vinereanu, D., Lopes, R.D., Mulder, H., Gersh, B.J., Hanna, M., De Barros E Silva, P.G.M., Atar, D., Wallentin, L., Granger, C.B., Alexander, J.H.

Get full text

Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial by Røsjø, H., Hijazi, Z., Omland, T., Westerbergh, J., Lyngbakken, M.N., Alexander, J.H., Gersh, B.J., Granger, C.B., Hylek, E.M., Lopes, R.D., Siegbahn, A., Wallentin, L.

“…Background Cardiac troponin T (cTnT) and I (cTnI) concentrations provide strong prognostic information in anticoagulated patients with atrial fibrillation…”
Get full text

P2685INR prior to bleeding is below 3.0 most of the time in patients with atrial fibrillation using warfarin by Oliveira Guimaraes, P., Lopes, R.D., Alexander, J.H., Thomas, L., Hellkamp, A.S., Wallentin, L., Hylek, E.M., Gersh, B.J., Garcia, D.A., Verheugt, F.W.A., Hanna, M., Flaker, G.C., Vinereanu, D., Granger, C.B.

Get full text

PCV3 - Antithrombotic Strategies and Adverse Outcomes in Acute Coronary Syndrome and Atrial Fibrillation: A Community Study by Chamberlain, A.M., Gersh, B.J., Klaskala, W., Mills, R.M., Alonso, A., Weston, S.A., Roger, V.L.

Get full text

PCV143 - Antithrombotic strategies in acute coronary syndrome and atrial fibrillation: A community perspective by Chamberlain, A.M., Gersh, B.J., Klaskala, W., Mills, R.M., Alonso, A., Weston, S.A., Roger, V.L.

Get full text

Effect of Low-Dose Rapamycin on Senescence Markers and Physical Functioning in Older Adults with Coronary Artery Disease: Results of a Pilot Study by Singh, M, Jensen, M D, Lerman, A, Kushwaha, S, Rihal, C S, Gersh, B J, Behfar, A, Tchkonia, T, Thomas, R J, Lennon, R J, Keenan, L R, Moore, A G, Kirkland, J L

“…Rapamycin, an mTOR inhibitor affects senescence through suppression of senescence-associated secretory phenotype (SASP). We studied the safety and feasibility…”
Get more information